HomeCompareCYBN vs PM

CYBN vs PM: Dividend Comparison 2026

CYBN yields 24.15% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBN wins by $44.3K in total portfolio value
10 years
CYBN
CYBN
● Live price
24.15%
Share price
$8.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.9K
Annual income
$10,269.79
Full CYBN calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — CYBN vs PM

📍 CYBN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBNPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBN + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBN pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBN
Annual income on $10K today (after 15% tax)
$2,053.14/yr
After 10yr DRIP, annual income (after tax)
$8,729.32/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, CYBN beats the other by $6,611.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBN + PM for your $10,000?

CYBN: 50%PM: 50%
100% PM50/50100% CYBN
Portfolio after 10yr
$71.7K
Annual income
$6,380.90/yr
Blended yield
8.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

CYBN
No analyst data
Altman Z
4.3
Piotroski
0/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBN buys
0
PM buys
0
No recent congressional trades found for CYBN or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBNPM
Forward yield24.15%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$93.9K$49.6K
Annual income after 10y$10,269.79$2,492.02
Total dividends collected$58.5K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CYBN vs PM ($10,000, DRIP)

YearCYBN PortfolioCYBN Income/yrPM PortfolioPM Income/yrGap
1← crossover$13,115$2,415.46$11,648$408.29+$1.5KCYBN
2$16,994$2,960.73$13,589$495.90+$3.4KCYBN
3$21,769$3,585.38$15,877$603.21+$5.9KCYBN
4$27,585$4,292.32$18,580$734.88+$9.0KCYBN
5$34,600$5,083.28$21,781$896.75+$12.8KCYBN
6$42,980$5,958.72$25,578$1,096.12+$17.4KCYBN
7$52,907$6,917.79$30,092$1,342.17+$22.8KCYBN
8$64,569$7,958.38$35,470$1,646.46+$29.1KCYBN
9$78,166$9,077.18$41,892$2,023.58+$36.3KCYBN
10$93,907$10,269.79$49,578$2,492.02+$44.3KCYBN

CYBN vs PM: Complete Analysis 2026

CYBNStock

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Full CYBN Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this CYBN vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBN vs SCHDCYBN vs JEPICYBN vs OCYBN vs KOCYBN vs MAINCYBN vs MOCYBN vs BTICYBN vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.